Clinical StudiesFluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthma
References (20)
- et al.
Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
Respir Med
(1994) - et al.
Dose related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
J Allergy Clin Immunol
(1995) Growth in asthmatic children treated with fluticasone propionate: Setting a new standard in study design
J Pediatr
(1998)- et al.
Effectiveness of fluticasone propionate in patients with moderate asthma: A dose ranging study
Clin Ther
(1996) - et al.
Airway inflammation in mild intermittent and in persistent asthma
Am J Respir Crit Care Med
(1998) The British Guidelines on Asthma Management 1995 review and position statement
Thorax
(1997)- et al.
Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding corticosteroids
Ann Intern Med
(1993) - et al.
Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate
Am J Respir Crit Care Med
(1995) - et al.
One year treatment with salmeterol compared with beclomethasone in children with asthma
Am J Respir Crit Care Med
(1997)
Cited by (39)
The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis
2022, Clinical ImmunologyCitation Excerpt :The P value of Begg's rank correlation test (STATA 12.0) was used to assess the presence of publication bias in included articles for each outcome. Of 17,234 trials recognized by the initial search, 331 were retrieved for more detailed assessment, and 86 trials [8–91,105–107] were included in the meta-analysis (Fig. 1). Baseline characteristics of trials included in the meta-analysis are shown in Table 1.
Individualized homeopathy in a group of Egyptian asthmatic children
2012, HomeopathyCitation Excerpt :Several placebo-controlled trials among children 4–11 years of age compared fluticasone with placebo during a 12-week, double-blind period. After 12 weeks, the improvement in FEV1 for patients receiving 100 μg of fluticasone twice per day was 0.23L, 0.25L and 0.27L with little placebo effect.29–31 Our study showed a significant increase of 0.21L in FEV1(13%) after 6 months of treatment with homeopathic medicines.
The treatment of asthma in children: Inhaled corticosteroids
2007, Pulmonary Pharmacology and TherapeuticsCitation Excerpt :Again no significant difference was seen between any of the individual doses used in the study. The effect of 100 and 200 μg/d FP Diskhaler was compared with that of placebo among 263 children with asthma [54]. Both doses of FP led to significant improvements in PEF and asthma symptom score over 6 and 12 weeks, but no significant difference was seen between the effects of the two doses of FP in any other measured parameter.
Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: A randomized, double-blind, placebo-controlled study
2006, Journal of PediatricsCitation Excerpt :Overall FP systemic exposure was low and was not associated with changes in urine cortisol excretion from baseline. A similar lack of effect of FP on UC excretion was observed in other studies in children.4,15,21-28 Specifically, there was no correlation between FP systemic exposure and change in UC from baseline.
- 1
Members of the Fluticasone Propionate Study Group are listed in the Acknowledgments.